ViroCarb is a startup based in the United States.
ViroCarb develops broad-spectrum antiviral therapies focused on treating and preventing viral infections such as COVID-19, HIV, Herpes, and Coronavirus.
Funding rounds, investor list, risk signals, and comparable startups, all gated to subscribers.